The University at Buffalo (UB) research teams of Robert M. Straubinger, PhD, UB Distinguished Professor, and Jun Qu, PhD, Professor, both of the Department of Pharmaceutical Sciences, recently published a research article in Molecular & Cellular Proteomics, a top international proteomics journal, describing their work in identifying key metabolic regulators involved in cancer cell resistance to gemcitabine (Gem), a standard-of-care chemotherapy for pancreatic dual adenocarcinoma (PDAC), the most lethal type of pancreatic cancer. The team also includes William J. Jusko, PhD, SUNY Distinguished Professor, and several of his lab members.